By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration passed trade secrets…
Nov 15 (Reuters) – Canadian wholesale trade increased by 0.1% in September from August on the higher sales in the personal and household goods subsector, and in particular pharmaceutical products,…
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix…
Luzsana to co-develop medicines with parent company Hengrui Pharma and commercialize in North America, Europe and Japan Initial pipeline focuses on 11 high-potential programs in areas of high unmet need,…
NEW ORLEANS, April 22, 2022 — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces…
Featured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide) Research BRIDGEWATER, N.J., April 7, 2022 — Salix Pharmaceuticals (“Salix”), the gastroenterology business of Bausch Health Companies Inc. (NYSE/TSX: BHC)…
Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion, USP to address current market shortage Tweet this About Propofol Propofol injectable emulsion is an intravenous general anesthetic and sedation…
VANCOUVER, BC, March 30, 2022 — The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the…
“We are pleased to collaborate with Seton Pharmaceuticals for the commercial launch of Butalbital, Acetaminophen and Caffeine Capsules in the U.S. market” stated Dhananjay Barot, Director, Senores Pharmaceuticals, Inc. “Our unfaltering…